IP Library › Granted Patent US 10,190,143
Granted Patent B2
US 10,190,143 · App. 14/903,738 · Granted Jan 29, 2019

Method for synthesizing selectively labeled RNA

Inventors: Yun-Xing Wang (Frederick, MD); Yu Liu (Frederick, MD); Rui Sousa (San Antonio, TX)
Assignees: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES OFFICE OF TECHNOLOGY TRANSFER, NATIONAL INSTITUTES OF HEALTH
C12P19/34C12Q1/6844
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,190,143
App. No.
14/903,738
Granted
Jan 29, 2019
Kind
B2
Abstract

The invention relates to a method for synthesizing a selectively labeled RNA, and an apparatus for performing the method. Specific segments or discrete residues within the RNA may be selectively labeled, and different segments may include different labels.

Claims (34)

1. A method for synthesizing a RNA, comprising performing an initiation stage, an elongation stage, and a termination stage, wherein:

(a) the initiation stage comprises:

(i) providing a solid phase comprising a DNA template, wherein the DNA is attached to a solid substrate;

(ii) providing a first liquid phase comprising a RNA polymerase and ribonucleoside triphosphates (rNTPs);

(iii) mixing the solid phase and first liquid phase;

(iv) incubating the solid phase and first liquid phase at 4-37° C. for 5-30 minutes to initiate synthesis of the RNA;

(v) pausing the RNA synthesis by incubating the solid phase and first liquid phase at 0-5° C., whereupon the solid phase comprises the RNA polymerase and the RNA being synthesized; and

(vi) separating the solid phase from the first liquid phase;

(b) the elongation stage comprises:

(i) providing a second liquid phase comprising rNTPs;

(ii) mixing the solid phase and second liquid phase;

(iii) incubating the solid phase and second liquid phase at 4-37° C. for 5-20 minutes to elongate the RNA;

(iv) pausing the RNA synthesis by incubating the solid phase and second liquid phase at 0-5° C. for 5-30 minutes;

(v) separating the solid phase from the second liquid phase; and

(vi) repeating steps (i)-(v) of part (b) n times, wherein n is equal to 1-100, and wherein the rNTPs in the second liquid phase are the same or different in each repeat;

(c) the termination stage comprises:

(i) providing a third liquid phase comprising rNTPs;

(ii) mixing the solid phase with the third liquid phase;

(iii) incubating the solid phase and third liquid phase at 4-37° C. for 5-30 minutes; and

(iv) pausing the RNA synthesis by incubating the solid phase and third liquid phase at 0° C. for 5-30 minutes; wherein steps (a)-(c) are repeated multiple times, and wherein rNTPs of at least one of the first liquid phase, the second liquid phase, or third liquid phase comprise a label.

2. The method of claim 1 , wherein the solid substrate is a bead comprising a gel, glass, or a synthetic polymer.

3. The method of claim 2 , wherein the bead has a diameter of 5-100 μm.

4. The method of claim 1 , wherein the ratio of concentration of rNTPs to DNA is 1-100.

5. The method of claim 1 , wherein the RNA polymerase is T7 RNA polymerase.

6. The method of claim 1 , wherein the label is selected from the group consisting of 13 C/ 15 N, 2 H, Cy3, Cy5, a fluorophore, a heavy atom, and a chemical modification.

7. The method of claim 1 , wherein any one of the mixing steps is performed under an inert atmosphere.

8. The method of claim 1 , wherein the mixing does not cause the liquid phases to form bubbles.

9. The method of claim 8 , wherein the mixing comprises rotating the reaction 360 degrees.

10. The method of claim 1 , wherein the RNA synthesis is carried out in a reaction vessel of an automated platform.

11. The method of claim 10 , wherein the reaction vessel is in operative association with a motor that manipulates the reaction vessel through a gear arrangement that is operatively engaged with the motor, and wherein the motor is in operative association with a computer processor for controlling the automated platform and for manipulation of the reaction vessel.

12. The method of claim 11 , wherein the apparatus comprises a holder for receiving and manipulating the reaction vessel.

13. The method of claim 12 , wherein the holder manipulates the reaction vessel to mix the liquid phases during the RNA synthesis.

14. The method of claim 13 , wherein the mixing does not stir, shake, or bubble the liquid phases of the RNA synthesis.

15. The method of claim 14 , wherein the reaction vessel is rotated 360 degrees by the holder.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2016
From: WANG, YUN-XING; LIU, YU
To: THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 038285/0702 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 14, 2016
From: SOUSA, RUI
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 038434/0839 →
Continuity (2)
Provisional Application 61843864 · Jul 8, 2013
Related Publication 20160160256A1 · Jun 9, 2016